ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

GAO Eppley Report Offers Lessons for Grantees, Contractors

March 3, 1978

Duke Picks Lyerly To Direct Cancer Center

May 2, 2003

Obituaries: Sylvan Green, Donald Gleason

January 23, 2009

Bonadonna’s Study At Four Years: CMF Group Still Doing Better

November 24, 1978

Broder: Downward Negotiations Or Coercion? NCI Authorities

June 15, 1990

Conversation With The Cancer Letter: How ASCO’s Guideline Differs—And Why

July 20, 2012